Skip to main
CCRN
CCRN logo

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 4 analyst ratings
Hold
Strong Buy 25%
Buy 0%
Hold 75%
Sell 0%
Strong Sell 0%

Bulls say

Cross Country Healthcare has demonstrated stabilization in its gross margin, maintaining a rate of 20.0%, which is consistent with the previous quarter and surpasses prior estimates. Additionally, the company is set to be acquired by Aya Healthcare for $18.61 per share in cash, reflecting a significant 67% premium over its closing price before the announcement. This acquisition, expected to close in the second half of 2025, enhances Cross Country's valuation outlook amidst a positive financial backdrop.

Bears say

Cross Country Healthcare reported a significant decline in adjusted EBITDA, falling 44% year-over-year to $8.6 million in Q1/25, despite surprising on estimates due to revenue shortfalls. Additionally, the company’s Q1/25 revenue of $293.4 million was 23% lower than the previous year and did not meet both internal and consensus forecasts, reflecting ongoing weaker demand in the healthcare travel staffing sector. Consequently, revenue projections for 2025 have been revised downward to $1.166 billion, representing a decline of 13.3% from prior estimates.

CCRN has been analyzed by 4 analysts, with a consensus rating of Hold. 25% of analysts recommend a Strong Buy, 0% recommend Buy, 75% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 4 analysts, CCRN has a Hold consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.